INIS
antibodies
92%
delivery
92%
stem cells
63%
alginates
53%
monoclonal antibodies
50%
encapsulation
46%
regeneration
46%
modifications
46%
bones
46%
cost
41%
applications
35%
proposals
33%
cancer
26%
nutrients
23%
capsules
18%
polymers
18%
purification
16%
levels
16%
diseases
16%
production
16%
patients
16%
tissues
16%
orau
16%
clinical trials
15%
drugs
9%
inclusions
9%
engineers
9%
therapy
9%
vectors
9%
membranes
9%
dna
9%
diffusion
9%
host
9%
commercialization
7%
testing
7%
cell membranes
6%
genetics
6%
defects
6%
surfaces
6%
oxygen
6%
proliferation
6%
increasing
6%
pools
6%
fractures
6%
osteoblasts
6%
hydrogels
6%
viability
6%
engineering
6%
supply
6%
reviews
6%
healing
6%
critical size
6%
Keyphrases
Microencapsulated Cells
92%
Therapeutic Antibody
92%
Sustained Delivery
92%
Monoclonal Antibody
92%
Encapsulated Cells
61%
Mesenchymal Stem Cells
30%
Microcapsules
30%
Allogeneic Cells
30%
Cancer Disease
30%
Genetic Engineering
30%
Medical Conditions
30%
Clinically Significant
30%
Antibodies Monoclonal
30%
Delivery Cost
30%
Antibody Delivery
30%
Autoimmune Disease
30%
Functional Antibodies
30%
Monospecific Antibody
30%
Immune Isolation
30%
Biocompatibility
30%
Anticancer Agents
30%
Kohler
30%
Alginate Microcapsules
15%
Immune Cells
15%
High Cost
15%
In Cancer
15%
Modification Engineering
15%
Bidirectional Exchange
9%
Immunology and Microbiology
Cell Encapsulation
100%
Monospecific Antibody
92%
Therapeutic Antibodies
92%
Monoclonal Antibody
80%
Autoimmune Disease
26%
Immunocompetent Cell
16%
Mesenchymal Stem Cell
11%
Mediator
9%
Immune Response
9%
Immunogenicity
9%